{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:22:39Z","timestamp":1794381759803,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51645-1","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T07:25:56Z","timestamp":1779521156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The interplay between tumor-intrinsic KRT6A and host-derived immune-nutritional status (PNI) defines prognosis in resectable PDAC"],"prefix":"10.1038","volume":"16","author":[{"given":"Fangfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaocheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"1","key":"51645_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74(1), 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"8\u20139","key":"51645_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/carcin\/bgad056","volume":"44","author":"M Giaccherini","year":"2023","unstructured":"Giaccherini, M. et al. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma. Carcinogenesis 44(8\u20139), 642\u2013649. https:\/\/doi.org\/10.1093\/carcin\/bgad056 (2023).","journal-title":"Carcinogenesis"},{"issue":"1","key":"51645_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010056","volume":"16","author":"A Pantaleo","year":"2023","unstructured":"Pantaleo, A. et al. Understanding the genetic landscape of pancreatic ductal adenocarcinoma to support personalized medicine: A systematic review. Cancers (Basel) 16(1), 56. https:\/\/doi.org\/10.3390\/cancers16010056 (2023).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"51645_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","volume":"13","author":"C Falcomat\u00e0","year":"2023","unstructured":"Falcomat\u00e0, C. et al. Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer. Cancer Discov. 13(2), 278\u2013297. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0876 (2023).","journal-title":"Cancer Discov."},{"issue":"1","key":"51645_CR5","doi-asserted-by":"publisher","first-page":"15598","DOI":"10.1038\/s41598-024-65900-w","volume":"14","author":"T Shibayama","year":"2024","unstructured":"Shibayama, T. et al. Combination immunohistochemistry for CK5\/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-na\u00efve pancreatic ductal adenocarcinoma. Sci. Rep. 14 (1), 15598. https:\/\/doi.org\/10.1038\/s41598-024-65900-w (2024). PMID: 38971768; PMCID: PMC11227498.","journal-title":"Sci. Rep."},{"issue":"10","key":"51645_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47(10), 1168\u201378. https:\/\/doi.org\/10.1038\/ng.3398 (2015).","journal-title":"Nat. Genet."},{"issue":"8","key":"51645_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/cts.13563","volume":"16","author":"M Posta","year":"2023","unstructured":"Posta, M. & Gy\u0151rffy, B. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clin. Transl. Sci. 16(8), 1479\u20131491. https:\/\/doi.org\/10.1111\/cts.13563 (2023).","journal-title":"Clin. Transl. Sci."},{"issue":"6","key":"51645_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08572-6","volume":"32","author":"M Keskinkilic","year":"2024","unstructured":"Keskinkilic, M., Semiz, H. S., Ataca, E. & Yavuzsen, T. The prognostic value of immune-nutritional status in metastatic colorectal cancer: Prognostic nutritional index (PNI). Support. Care Cancer 32(6), 374. https:\/\/doi.org\/10.1007\/s00520-024-08572-6 (2024).","journal-title":"Support. Care Cancer"},{"issue":"1","key":"51645_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13244-z","volume":"24","author":"S Kawahara","year":"2024","unstructured":"Kawahara, S. et al. Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection. BMC Cancer 24(1), 1469. https:\/\/doi.org\/10.1186\/s12885-024-13244-z (2024).","journal-title":"BMC Cancer"},{"issue":"4","key":"51645_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.24875\/CIRU.22000544","volume":"92","author":"K Eyvaz","year":"2024","unstructured":"Eyvaz, K. et al. Preoperative neutrophil-to-C-reactive protein ratio as a predictor of post-operative complications of pancreas cancer. Cir. Cir. 92(4), 481\u2013486. https:\/\/doi.org\/10.24875\/CIRU.22000544 (2024).","journal-title":"Cir. Cir."},{"key":"51645_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1166860","volume":"13","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. Front. Oncol. 13, 1166860. https:\/\/doi.org\/10.3389\/fonc.2023.1166860 (2023).","journal-title":"Front. Oncol."},{"issue":"8","key":"51645_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","volume":"10","author":"AL Blackford","year":"2024","unstructured":"Blackford, A. L. et al. Pancreatic cancer surveillance and survival of high-risk individuals. JAMA Oncol. 10(8), 1087\u20131096. https:\/\/doi.org\/10.1001\/jamaoncol.2024.1930 (2024).","journal-title":"JAMA Oncol."},{"key":"51645_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1636715","volume":"15","author":"L Huan","year":"2025","unstructured":"Huan, L., He, Q., Cao, Y., Liu, C. & Li, Y. Development and validation of a prognostic nomogram for unresectable pancreatic ductal adenocarcinoma with synchronous liver metastases: A study based on the SEER database and an external cohort. Front. Oncol. 15, 1636715. https:\/\/doi.org\/10.3389\/fonc.2025.1636715 (2025).","journal-title":"Front. Oncol."},{"key":"51645_CR14","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma. Version 2.2024. (Accessed 9 February 2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf\u00a0(2024)."},{"issue":"12","key":"51645_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113434","volume":"42","author":"Y Ohara","year":"2023","unstructured":"Ohara, Y. et al. SERPINB3-MYC axis induces the basal-like\/squamous subtype and enhances disease progression in pancreatic cancer. Cell Rep. 42(12), 113434. https:\/\/doi.org\/10.1016\/j.celrep.2023.113434 (2023).","journal-title":"Cell Rep."},{"key":"51645_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102532","volume":"61","author":"Q Chi","year":"2025","unstructured":"Chi, Q. et al. Integrated transcriptome and single-cell RNA sequencing analysis revealed the prognostic significance of GBP4 in pancreatic adenocarcinoma. Transl. Oncol. 61, 102532. https:\/\/doi.org\/10.1016\/j.tranon.2025.102532 (2025).","journal-title":"Transl. Oncol."},{"issue":"3","key":"51645_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cpt.2024.07.004","volume":"3","author":"R Liu","year":"2024","unstructured":"Liu, R., Li, J., Liu, L., Wang, W. & Jia, J. Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Cancer Pathog. Ther. 3(3), 183\u2013196. https:\/\/doi.org\/10.1016\/j.cpt.2024.07.004 (2024).","journal-title":"Cancer Pathog. Ther."},{"issue":"1","key":"51645_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010579","volume":"13","author":"A Lahusen","year":"2025","unstructured":"Lahusen, A. et al. Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. J Immunother Cancer 13(1), e010579. https:\/\/doi.org\/10.1136\/jitc-2024-010579 (2025).","journal-title":"J Immunother Cancer"},{"issue":"8","key":"51645_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI189513","volume":"135","author":"REA Fincham","year":"2025","unstructured":"Fincham, R. E. A., Yeong, J. P. S. & Kocher, H. M. Developing cell-based therapies for pancreatic ductal adenocarcinoma. J. Clin. Invest. 135(8), e189513. https:\/\/doi.org\/10.1172\/JCI189513 (2025).","journal-title":"J. Clin. Invest."},{"issue":"5","key":"51645_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell 42(5), 885-903.e4. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.009 (2024).","journal-title":"Cancer Cell"},{"key":"51645_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080040","volume":"387","author":"MS Yule","year":"2024","unstructured":"Yule, M. S., Brown, L. R., Waller, R. & Wigmore, S. J. Cancer cachexia. BMJ 387, e080040. https:\/\/doi.org\/10.1136\/bmj-2024-080040 (2024).","journal-title":"BMJ"},{"issue":"1","key":"51645_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-024-02757-w","volume":"25","author":"Y Liu","year":"2025","unstructured":"Liu, Y. & Li, K. Predictive role of the prognostic nutritional index for long-term prognosis among patients undergoing pancreatoduodenectomy: A meta-analysis. BMC Surg. 25(1), 51. https:\/\/doi.org\/10.1186\/s12893-024-02757-w (2025).","journal-title":"BMC Surg."},{"issue":"1","key":"51645_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13523-3","volume":"25","author":"Y Yang","year":"2025","unstructured":"Yang, Y., Zong, S. & Hua, Y. Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemotherapy: Incorporating immune-inflammation scores and coagulation indicators. BMC Cancer 25(1), 107. https:\/\/doi.org\/10.1186\/s12885-025-13523-3 (2025).","journal-title":"BMC Cancer"},{"key":"51645_CR24","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.2147\/JIR.S519779","volume":"18","author":"D Qin","year":"2025","unstructured":"Qin, D. et al. Development of a nomogram integrating modified inflammation-based indexes for predicting overall survival in pancreatic cancer: A retrospective study. J. Inflamm. Res. 18, 4813\u20134830. https:\/\/doi.org\/10.2147\/JIR.S519779 (2025).","journal-title":"J. Inflamm. Res."},{"issue":"45","key":"51645_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045474","volume":"104","author":"K Li","year":"2025","unstructured":"Li, K., Xu, R., Yan, J., Guo, M. & Zhang, H. Development and validation of a nomogram to predict overall survival in elderly patients with pancreatic cancer without surgical treatment. Medicine (Baltimore) 104(45), e45474. https:\/\/doi.org\/10.1097\/MD.0000000000045474 (2025).","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"51645_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori, K. J. et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): A multicentre, randomised, phase 2 trial. Lancet Gastroenterol. Hepatol. 9(3), 205\u2013217. https:\/\/doi.org\/10.1016\/S2468-1253(23)00405-3 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"51645_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/SLA.0000000000006468","volume":"280","author":"J Pinson","year":"2024","unstructured":"Pinson, J. et al. New biomarkers to define a biological borderline situation for pancreatic adenocarcinoma: Results of an ancillary study of the PANACHE01-PRODIGE48 trial. Ann. Surg. 280(5), 734\u2013744. https:\/\/doi.org\/10.1097\/SLA.0000000000006468 (2024).","journal-title":"Ann. Surg."},{"issue":"9","key":"51645_CR28","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00489","volume":"9","author":"L Rajdev","year":"2025","unstructured":"Rajdev, L. et al. Incorporating circulating tumor DNA testing into clinical trials: A position paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group. JCO Precis. Oncol. 9(9), e2400489. https:\/\/doi.org\/10.1200\/PO-24-00489 (2025).","journal-title":"JCO Precis. Oncol."}],"updated-by":[{"DOI":"10.1038\/s41598-026-76461-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:00:00Z","timestamp":1794268800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51645-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:36:04Z","timestamp":1794378964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51645-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51645-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-76461-5","URL":"https:\/\/doi.org\/10.1038\/s41598-026-76461-5","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study participants, or their legal guardian, provided informed written consent prior to study enrollment.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Chaoyang Hospital (acceptance number: 2024-D-511). All procedures in this study involving human partici pants were performed in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration.","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25282"}}